Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Healthcare Nanotechnology Market by Type (Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog), By Application (Anticancer, CNS Product, Anti-infective, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Healthcare Nanotechnology Market by Type (Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog), By Application (Anticancer, CNS Product, Anti-infective, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131882 3300 Medical Devices & Consumables 377 240 Pages 4.8 (34)
                                          

The global healthcare nanotechnology market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for nanomedicine and nano medical devices in the healthcare sector. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is also driving the growth of this market. Nanomedicine is one of the major segments in this market and it accounted for more than 50% share in 2018. This segment includes products such as nanoparticles, liposomes, dendrimers, quantum dots, and others that are used for diagnosis or treatment purposes. Nano medical devices accounted for more than 30% share in 2018 due to their wide range of applications including drug delivery systems (e.g., inhalers), diagnostic tools (e.g., MRI), surgical instruments (e.g., scalpels), implants (e.g., pacemakers) among others which are used by physicians across various specialties such as cardiology or oncology among others.

Some Of The Growth Factors Of This Market:

  1. The healthcare nanotechnology market is driven by the increasing demand for minimally invasive procedures, rising prevalence of chronic diseases, and growing geriatric population.
  2. Healthcare nanotechnology products are used in various applications such as drug delivery, diagnostics, and therapeutics.
  3. The healthcare nanotechnology market is segmented into product type (drug delivery systems, diagnostic tools & devices), application (diagnostic tools & devices), end user (hospitals & clinics).

Industry Growth Insights published a new data on “Healthcare Nanotechnology Market”. The research report is titled “Healthcare Nanotechnology Market research by Types (Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog), By Applications (Anticancer, CNS Product, Anti-infective, Others), By Players/Companies Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International, Healthcare Nanotechnolog”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Healthcare Nanotechnology Market Research Report

By Type

Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog

By Application

Anticancer, CNS Product, Anti-infective, Others

By Companies

Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International, Healthcare Nanotechnolog

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Healthcare Nanotechnology Industry Outlook


Global Healthcare Nanotechnology Market Report Segments:

The global Healthcare Nanotechnology market is segmented on the basis of:

Types

Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Anticancer, CNS Product, Anti-infective, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Amgen
  2. Teva Pharmaceuticals
  3. Abbott
  4. UCB
  5. Roche
  6. Celgene
  7. Sanofi
  8. Merck & Co
  9. Biogen
  10. Stryker
  11. Gilead Sciences
  12. Pfizer
  13. 3M Company
  14. Johnson & Johnson
  15. Smith & Nephew
  16. Leadiant Biosciences
  17. Kyowa Hakko Kirin
  18. Takeda
  19. Ipsen
  20. Endo International
  21. Healthcare Nanotechnolog

Global Healthcare Nanotechnology Market Overview


Highlights of The Healthcare Nanotechnology Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Nanomedicine
    2. Nano Medical Devices
    3. Nano Diagnosis
    4. Others
    5. Healthcare Nanotechnolog
  1. By Application:

    1. Anticancer
    2. CNS Product
    3. Anti-infective
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Healthcare Nanotechnology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Healthcare Nanotechnology Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Healthcare Nanotechnology Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Healthcare Nanotechnology Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Healthcare Nanotechnology Market - Supply Chain
   4.5. Global Healthcare Nanotechnology Market Forecast
      4.5.1. Healthcare Nanotechnology Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Healthcare Nanotechnology Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Healthcare Nanotechnology Market Absolute $ Opportunity

5. Global Healthcare Nanotechnology Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Healthcare Nanotechnology Market Size and Volume Forecast by Type
      5.3.1. Nanomedicine
      5.3.2. Nano Medical Devices
      5.3.3. Nano Diagnosis
      5.3.4. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Healthcare Nanotechnology Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Healthcare Nanotechnology Market Size and Volume Forecast by Application
      6.3.1. Anticancer
      6.3.2. CNS Product
      6.3.3. Anti-infective
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Healthcare Nanotechnology Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Healthcare Nanotechnology Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Healthcare Nanotechnology Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Healthcare Nanotechnology Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Healthcare Nanotechnology Demand Share Forecast, 2019-2029

9. North America Healthcare Nanotechnology Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Healthcare Nanotechnology Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Healthcare Nanotechnology Market Size and Volume Forecast by Application
      9.4.1. Anticancer
      9.4.2. CNS Product
      9.4.3. Anti-infective
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Healthcare Nanotechnology Market Size and Volume Forecast by Type
      9.7.1. Nanomedicine
      9.7.2. Nano Medical Devices
      9.7.3. Nano Diagnosis
      9.7.4. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Healthcare Nanotechnology Demand Share Forecast, 2019-2029

10. Latin America Healthcare Nanotechnology Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Healthcare Nanotechnology Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Healthcare Nanotechnology Market Size and Volume Forecast by Application
      10.4.1. Anticancer
      10.4.2. CNS Product
      10.4.3. Anti-infective
      10.4.4. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Healthcare Nanotechnology Market Size and Volume Forecast by Type
      10.7.1. Nanomedicine
      10.7.2. Nano Medical Devices
      10.7.3. Nano Diagnosis
      10.7.4. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Healthcare Nanotechnology Demand Share Forecast, 2019-2029

11. Europe Healthcare Nanotechnology Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Healthcare Nanotechnology Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Healthcare Nanotechnology Market Size and Volume Forecast by Application
      11.4.1. Anticancer
      11.4.2. CNS Product
      11.4.3. Anti-infective
      11.4.4. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Healthcare Nanotechnology Market Size and Volume Forecast by Type
      11.7.1. Nanomedicine
      11.7.2. Nano Medical Devices
      11.7.3. Nano Diagnosis
      11.7.4. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Healthcare Nanotechnology Demand Share, 2019-2029

12. Asia Pacific Healthcare Nanotechnology Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Healthcare Nanotechnology Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Healthcare Nanotechnology Market Size and Volume Forecast by Application
      12.4.1. Anticancer
      12.4.2. CNS Product
      12.4.3. Anti-infective
      12.4.4. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Healthcare Nanotechnology Market Size and Volume Forecast by Type
      12.7.1. Nanomedicine
      12.7.2. Nano Medical Devices
      12.7.3. Nano Diagnosis
      12.7.4. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Healthcare Nanotechnology Demand Share, 2019-2029

13. Middle East & Africa Healthcare Nanotechnology Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Healthcare Nanotechnology Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Healthcare Nanotechnology Market Size and Volume Forecast by Application
      13.4.1. Anticancer
      13.4.2. CNS Product
      13.4.3. Anti-infective
      13.4.4. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Healthcare Nanotechnology Market Size and Volume Forecast by Type
      13.7.1. Nanomedicine
      13.7.2. Nano Medical Devices
      13.7.3. Nano Diagnosis
      13.7.4. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Healthcare Nanotechnology Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Healthcare Nanotechnology Market: Market Share Analysis
   14.2. Healthcare Nanotechnology Distributors and Customers
   14.3. Healthcare Nanotechnology Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Amgen
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Teva Pharmaceuticals
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Abbott
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. UCB
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Roche
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Celgene
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Sanofi
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Merck & Co
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Biogen
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Stryker
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Gilead Sciences
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Pfizer
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. 3M Company
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Johnson & Johnson
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Smith & Nephew
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Leadiant Biosciences
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Kyowa Hakko Kirin
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Shire
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Ipsen
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. Endo International
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us